The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the launch of a pioneering Artificial Intelligence (AI) Sandbox, a first-of-its-kind regulatory initiative designed to support the safe adoption of AI in medicines development and strengthen drug safety monitoring across the healthcare sector. The programme will